Follow this preprint
Safety, efficacy and feasibility of preventive treatment for drug-resistant tuberculosis with moxifloxacin or bedaquiline
View ORCID ProfileAlexandra V. Solovyeva, View ORCID ProfileGrigory V. Volchenkov, Oksana I. Ponomarenko, Tatiana A. Kuznezova, Tatiana R. Somova, Evgenia V. Belova, View ORCID ProfileSven Gudmund Hinderaker, View ORCID ProfileEinar Heldal, View ORCID ProfileSalmaan Keshavjee
doi: https://doi.org/10.1101/2025.03.09.25323266
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Alexandra V. Solovyeva
1Independent Nonprofit Organization Center of Partnership Assistance in Healthcare “Zdorovye.ru”, Moscow, Russia
Grigory V. Volchenkov
2Vladimir Regional TB Control Center, Vladimir, Russia
Oksana I. Ponomarenko
1Independent Nonprofit Organization Center of Partnership Assistance in Healthcare “Zdorovye.ru”, Moscow, Russia
Tatiana A. Kuznezova
2Vladimir Regional TB Control Center, Vladimir, Russia
Tatiana R. Somova
2Vladimir Regional TB Control Center, Vladimir, Russia
Evgenia V. Belova
2Vladimir Regional TB Control Center, Vladimir, Russia
Sven Gudmund Hinderaker
3University of Bergen, Norway
Einar Heldal
4LHL International, Oslo, Norway
Salmaan Keshavjee
5Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA USA
6Division of Global Health Equity, Department of Medicine, Brigham and Women’s Hospital, Boston, MA USA
7Partners In Health, Boston, USA

Posted March 10, 2025.
Safety, efficacy and feasibility of preventive treatment for drug-resistant tuberculosis with moxifloxacin or bedaquiline
Alexandra V. Solovyeva, Grigory V. Volchenkov, Oksana I. Ponomarenko, Tatiana A. Kuznezova, Tatiana R. Somova, Evgenia V. Belova, Sven Gudmund Hinderaker, Einar Heldal, Salmaan Keshavjee
medRxiv 2025.03.09.25323266; doi: https://doi.org/10.1101/2025.03.09.25323266
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3133)
- Dermatology (266)
- Emergency Medicine (464)
- Epidemiology (13089)
- Forensic Medicine (14)
- Gastroenterology (871)
- Genetic and Genomic Medicine (4904)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3094)
- Health Policy (1110)
- Hematology (411)
- HIV/AIDS (975)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (504)
- Neurology (4674)
- Nursing (248)
- Nutrition (691)
- Oncology (2409)
- Ophthalmology (685)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (312)
- Palliative Medicine (88)
- Pathology (521)
- Pediatrics (1252)
- Primary Care Research (526)
- Public and Global Health (7233)
- Radiology and Imaging (1616)
- Respiratory Medicine (946)
- Rheumatology (463)
- Sports Medicine (405)
- Surgery (520)
- Toxicology (65)
- Transplantation (223)
- Urology (193)